Medical Cannabis and Conditions Affecting Assigned Female At Birth and Intersex People (for Doctors)
-
Overview
Designed for doctors, this course delves into a range of conditions that are uniquely prevalent among people assigned female at birth and intersex individuals with female reproductive organs. These conditions often go underrecognised and can profoundly affect health and quality of life. Conventional treatments sometimes fail to fully address these issues and can carry significant risks.
With medical cannabis emerging as a promising alternative, this course offers evidence-based insights into its potential for managing symptoms of:
- Endometriosis
- Dysmenorrhoea
- Polycystic Ovary Syndrome (PCOS)
- Premenstrual Dysphoric Disorder (PMDD)
- Postpartum Depression (PPD)
- Breast, ovarian, and uterine cancers
- Perimenopause and menopause
Additionally, it covers critical pregnancy-related contraindications for medical cannabis.
Healthcare professionals will gain crucial knowledge and skills to expand their therapeutic toolkit, integrating both traditional and cannabis-based approaches to enhance patient outcomes.
This is an opportunity to stay at the forefront of medical advancements and provide innovative care options for your patients.
Preview this course by watching the video above.
Estimated Duration: 5.5 hours
Access Duration: 12 months from date of purchase
Learning Outcomes
Upon completion of this course, you’ll be able to:
- Describe and explain the causes, symptoms, effects, and risk factors for various reproductive health conditions, including perimenopause, menopause, breast, ovarian, and uterine cancers, dysmenorrhoea, endometriosis, polycystic ovarian syndrome (PCOS), premenstrual dysphoric disorder (PMDD), and postpartum depression (PPD)
- Identify and evaluate common conventional treatment options for these conditions and their potential drawbacks
- Discuss the therapeutic potential of medical cannabis for treating symptoms of these reproductive health conditions
- Identify considerations for selecting suitable medical cannabis products for treating symptoms related to these conditions
- Identify TGA guidelines on contraindications for medical cannabis use during pregnancy and chest-feeding
- Discuss potential short and long-term risks of early cannabis exposure
- Explain the role of the endocannabinoid system in reproductive function
- Describe the risks of cannabis use during pregnancy, planning to become pregnant, and postnatal phases for both the foetus or infant and the birth-giver
Overview
Designed for doctors, this course delves into a range of conditions that are uniquely prevalent among people assigned female at birth and intersex individuals with female reproductive organs. These conditions often go underrecognised and can profoundly affect health and quality of life. Conventional treatments sometimes fail to fully address these issues and can carry significant risks.
With medical cannabis emerging as a promising alternative, this course offers evidence-based insights into its potential for managing symptoms of:
- Endometriosis
- Dysmenorrhoea
- Polycystic Ovary Syndrome (PCOS)
- Premenstrual Dysphoric Disorder (PMDD)
- Postpartum Depression (PPD)
- Breast, ovarian, and uterine cancers
- Perimenopause and menopause
Additionally, it covers critical pregnancy-related contraindications for medical cannabis.
Healthcare professionals will gain crucial knowledge and skills to expand their therapeutic toolkit, integrating both traditional and cannabis-based approaches to enhance patient outcomes.
This is an opportunity to stay at the forefront of medical advancements and provide innovative care options for your patients.
Preview this course by watching the video above.
Estimated Duration: 5.5 hours
Access Duration: 12 months from date of purchase
Learning Outcomes
Upon completion of this course, you’ll be able to:
- Describe and explain the causes, symptoms, effects, and risk factors for various reproductive health conditions, including perimenopause, menopause, breast, ovarian, and uterine cancers, dysmenorrhoea, endometriosis, polycystic ovarian syndrome (PCOS), premenstrual dysphoric disorder (PMDD), and postpartum depression (PPD)
- Identify and evaluate common conventional treatment options for these conditions and their potential drawbacks
- Discuss the therapeutic potential of medical cannabis for treating symptoms of these reproductive health conditions
- Identify considerations for selecting suitable medical cannabis products for treating symptoms related to these conditions
- Identify TGA guidelines on contraindications for medical cannabis use during pregnancy and chest-feeding
- Discuss potential short and long-term risks of early cannabis exposure
- Explain the role of the endocannabinoid system in reproductive function
- Describe the risks of cannabis use during pregnancy, planning to become pregnant, and postnatal phases for both the foetus or infant and the birth-giver